AU2003273142A1 - Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system - Google Patents

Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system Download PDF

Info

Publication number
AU2003273142A1
AU2003273142A1 AU2003273142A AU2003273142A AU2003273142A1 AU 2003273142 A1 AU2003273142 A1 AU 2003273142A1 AU 2003273142 A AU2003273142 A AU 2003273142A AU 2003273142 A AU2003273142 A AU 2003273142A AU 2003273142 A1 AU2003273142 A1 AU 2003273142A1
Authority
AU
Australia
Prior art keywords
nucleic acid
seqid
acid expression
expression construct
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003273142A
Other languages
English (en)
Inventor
Heather Attra
Robert H. Carpenter
Ruxandra Draghia-Akli
Henry Hebel
Leigh Anne Hill
Douglas R. Kern
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Advisys Inc
Original Assignee
Baylor College of Medicine
Advisys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/395,709 external-priority patent/US20040014645A1/en
Application filed by Baylor College of Medicine, Advisys Inc filed Critical Baylor College of Medicine
Publication of AU2003273142A1 publication Critical patent/AU2003273142A1/en
Assigned to BAYLOR COLLEGE OF MEDICINE reassignment BAYLOR COLLEGE OF MEDICINE Request for Assignment Assignors: ADVISYS, INC.
Assigned to BAYLOR COLLEGE OF MEDICINE ADVISYS, INC. reassignment BAYLOR COLLEGE OF MEDICINE ADVISYS, INC. Alteration of Name(s) of Applicant(s)/Patentee(s) Assignors: BAYLOR COLLEGE OF MEDICINE
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2003273142A 2002-05-28 2003-05-23 Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system Abandoned AU2003273142A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15667002A 2002-05-28 2002-05-28
US10/156,670 2002-05-28
US10/395,709 US20040014645A1 (en) 2002-05-28 2003-03-24 Increased delivery of a nucleic acid construct in vivo by the poly-L-glutamate ("PLG") system
US10/395,709 2003-03-24
PCT/US2003/016541 WO2003099341A1 (en) 2002-05-28 2003-05-23 Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system

Publications (1)

Publication Number Publication Date
AU2003273142A1 true AU2003273142A1 (en) 2003-12-12

Family

ID=29586320

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003273142A Abandoned AU2003273142A1 (en) 2002-05-28 2003-05-23 Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system

Country Status (7)

Country Link
EP (1) EP1513559A4 (de)
CN (1) CN1662261A (de)
AU (1) AU2003273142A1 (de)
BR (1) BR0311539A (de)
CA (1) CA2485976A1 (de)
MX (1) MXPA04011766A (de)
WO (1) WO2003099341A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005089810A1 (ja) * 2004-03-22 2008-01-31 関西ティー・エル・オー株式会社 エレクトロポレーション法を用いたヒト骨形成因子遺伝子導入による骨誘導方法
NZ553274A (en) * 2004-07-23 2010-02-26 VGX Pharmaceuticals LLC Growth hormone releasing hormone enhances the immune response induced by vaccination

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE309358T1 (de) * 1999-07-26 2005-11-15 Baylor College Medicine Superaktive, wachstumshormone freisetzende hormonanaloge vom schwein
CA2401327C (en) * 2000-03-03 2014-05-06 Valentis, Inc. Nucleic acid formulations comprising poly-amino acids for gene delivery and methods of use
EP1465654B1 (de) * 2001-12-11 2015-02-25 Inovio Pharmaceuticals, Inc. Durch plasmid übertragene supplementierung zur behandlung chronisch kranker patienten

Also Published As

Publication number Publication date
CA2485976A1 (en) 2003-12-04
BR0311539A (pt) 2005-10-25
MXPA04011766A (es) 2005-03-31
CN1662261A (zh) 2005-08-31
EP1513559A4 (de) 2006-01-18
EP1513559A1 (de) 2005-03-16
WO2003099341A1 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
Muramatsu et al. In vivo electroporation: a powerful and convenient means of nonviral gene transfer to tissues of living animals
McMahon et al. Electroporation for gene transfer to skeletal muscles: current status
US7173116B2 (en) Nucleic acid formulations for gene delivery and methods of use
US7570992B2 (en) Electrical field therapy with reduced histopathological change in muscle
US8178504B2 (en) Gene therapy expression of GHRH for increasing RBC count in subjects
Trollet et al. Electrotransfer into skeletal muscle for protein expression
EP1499731B1 (de) Veränderte hirnanhangsdrüsenentwicklung in nachkommen von mit einer therapie mit wachstumshormon freisetzendem hormon behandelten trächtigen muttertieren
Draghia-Akli et al. Electrical enhancement of formulated plasmid delivery in animals
AU2003273142A1 (en) Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system
US8962818B2 (en) Compositions comprising GHRH and GnRH and methods of using the same
US20080269153A1 (en) Increased stability of a dna formulation by including poly-l-glutamate
CA2563312C (en) Plasmid mediated ghrh supplementation for renal failures
US8481504B2 (en) Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications
Draghia-Akli et al. Plasmid-based expression technology using growth hormone releasing hormone: a novel method for physiologically stimulating long-term growth hormone secretion
KR20230061507A (ko) 생체 내 림프정맥 문합
Draghia-Akli et al. Electrokinetic enhancement of plasmid delivery in vivo
CA2575926A1 (en) Canine specific growth hormone releasing hormone
Trollet et al. DNA Pharmaceuticals: Formulation and Delivery in Gene Therapy, DNA Vaccination and Immunotherapy. Edited by Martin Schleef Copyright 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim ISBN: 3-527-31187-4
MC et al. GHRH ZUR VERWENDUNG BEI DER BEHANDLUNG VON CHRONISCHER NIERENINSUFFIZIENZ GHRH POUR LE TRAITEMENT DES INSUFFISANCES RENALES CHRONIQUES
CZ475699A3 (cs) Systém a zařízení pro in vivo přenos nukleových kyselin do tkání

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: BAYLOR COLLEGE OF MEDICINE

Free format text: FORMER APPLICANT(S): ADVISYS, INC.

TC Change of applicant's name (sec. 104)

Owner name: BAYLOR COLLEGE OF MEDICINE ADVISYS, INC.

Free format text: FORMER NAME: BAYLOR COLLEGE OF MEDICINE

TH Corrigenda

Free format text: IN VOL 20, NO 49, PAGE(S) 4923 UNDER THE HEADING ASSIGNMENTS BEFORE GRANT, SECTION 113 - 2003 UNDERTHE NAME BAYLOR COLLEGE OF MEDICINE, APPLICATION NO. 2003273142, UNDER INID(71), CORRECT TO READ BAYLOR COLLEGE OF MEDICINE ADVISYS, INC.

TH Corrigenda

Free format text: IN VOL 21, NO 3, PAGE(S) 306 UNDER THE HEADING CHANGE OF NAMES(S) OF APPLICANT(S), SECTION 104 - 2003 UNDER THE NAME BALOR COLLEGE OF MEDICINE ADVISYS, INC. APPLICATION NO.2003273142, UNDER INID(71), CORRECT TO READ BAYLOR COLLEGE OF MEDICINE AND ADVISYS, INC.

MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application